Exeed Regulatory Compliance

MARCH 22, 2020

Timely MDR reporting is a challenging regulatory requirement for the industry. A new FDA guidance provides much-needed relief during a pandemic. Adverse event reporting requirements are very stringent, and late reporting of such events is a routine focus of FDA inspections and subsequent warning letters.

FDA 52

FDA Nursing Homes Compliance COVID-19 52

Exeed Regulatory Compliance

APRIL 2, 2020

Market for interconnected medical devices is projected to grow but the regulatory pathway is still evolving. A new FDA guidance offers helpful recommendations for design and premarket submission. One way to understand how FDA is thinking about regulating these devices is to review recently cleared devices.

FDA 52

FDA Medical Device Industry Doctors Regulatory Compliance 52

Exeed Regulatory Compliance

JULY 6, 2020

Let us understand how they help and how FDA plans to regulate them. In this article, we explain the FDA requirements, and guidance for face masks when they are used for a medical purpose such as diagnosis, or cure, mitigation, treatment of prevention of disease.

COVID-19 52

COVID-19 FDA Medical Device Industry Public Health 52

Exeed Regulatory Compliance

JULY 10, 2020

The FDA is consistently updating its Guidance and policy for various Face Masks, Face Shields and Respirators as new information becomes available. We recently discussed the FDA’s policy for Face Masks during COVID-19. As a result, FDA has now established additional requirements for authorization of Respirators made in China.

COVID-19 52

COVID-19 FDA Medical Device Industry Public Health 52

Exeed Regulatory Compliance

AUGUST 3, 2020

Understanding the Available Diagnostic Tests As of this writing, the FDA has authorized 187 different tests, including 154 RT-PCR molecular diagnostic tests for COVID-19. FDA allowed physicians to order one of the authorized tests if they suspected COVID-19 even when the patient did not show any symptoms. CONTACT US.

COVID-19 52

COVID-19 FDA 52

Exeed Regulatory Compliance

FEBRUARY 25, 2020

Regulatory Breakthrough In a small step towards achieving the vision of interoperable medical devices, the FDA has recently authorized marketing of a novel software medical device using the De Novo Classification. the FDA expects for interoperable devices.

FDA 52

FDA 52

HIT Consultant

FEBRUARY 1, 2024

The challenges and considerations for pharmaceutical influencer marketing The challenges of pharma influencer marketing include choosing the right influencers, managing risks, and ensuring compliance with ethical guidelines; some specific challenges are: Regulatory Compliance The FDA regulates some aspects of pharma marketing.

Pharmaceutical Industry 111

Pharmaceutical Industry FDA Public Health Regulatory Compliance 111

Dot Compliance

JUNE 16, 2022

Millions of dollars are lost by manufacturers every year due to regulatory non-compliance issues and related lawsuits. We continuously hear of infractions and warnings issued to companies for lack of regulatory compliance. The QMS supports the manufacturers, leading to ISO confirmation and FDA compliance.

FDA 52

FDA Regulatory Compliance Compliance Governance 52

Dot Compliance

FEBRUARY 23, 2024

Their tasks included documenting quality processes, obtaining signatures from authorized individuals, and storing documents for regulatory compliance. Choose an eQMS provider with proven life sciences industry expertise and a platform preconfigured to industry standards like FDA, ISO, and GxP.

FDA 52

FDA Regulatory Compliance Compliance 52

Dot Compliance

FEBRUARY 22, 2022

FDA regulations govern what you can claim about your product and whether you can even sell it at all. For companies that manufacture drugs, biotechnology, and related products, demonstrating the safety and effectiveness of your goods to the FDA’s satisfaction has to be a top priority. What is the process for FDA drug approval?

FDA 98

FDA Compliance Governance Public Health 98

HIT Consultant

AUGUST 16, 2023

Accelerating the Adoption of IDMP-O to Simplify and Standardise data Assets “Fluree is a perfect fit for pharmaceutical organizations seeking to balance regulatory compliance with innovation and accelerate drug discovery, efficacy and efficiency,” said Eliud Polanco, Fluree president.

Pharmaceutical Industry 52

Pharmaceutical Industry Regulatory Compliance Compliance FDA 52

Verisys

NOVEMBER 30, 2022

Excluded from one means excluded from all, and the fines for non-compliance will likely be in the hundreds of thousands. Our FACIS database of more than 10 million records makes it easy to maintain regulatory compliance by identifying red-flag behaviors and trends for any individual you employ from 5,000+ sources. 52 AG Sources.

Regulatory Compliance 52

Regulatory Compliance Medicare Medicare Medicaid 52

Exeed Regulatory Compliance

MARCH 9, 2020

Here is an update on recent FDA activities. Cybersecurity of medical devices is on FDA’s radar! Just last week, the FDA issued a safety communication about the recently identified SweynTooth family of cybersecurity vulnerabilities which may affect medical devices. Please click on the video link below.

FDA 52

FDA Regulatory Compliance Compliance 52

Dot Compliance

JANUARY 4, 2022

For manufacturers the challenges of developing connected devices range from connectivity to regulatory compliance, but perhaps most important is cybersecurity. Use it to establish a credible, comprehensive data source for proactive, predictive quality management and effective AI application.

Regulatory Compliance 52

Regulatory Compliance Compliance COVID-19 FDA 52

AIHC

JUNE 14, 2023

Artificial Intelligence & Regulatory Compliance Written by Joanne Byron , BS, LPN, CCA, CHA, CHCO, CHBS, CHCM, CIFHA, CMDP, COCAS, CORCM, OHCC, ICDCT-CM/PCS This article follows Part 1 - Basics of Artificial Intelligence (AI) and Healthcare Compliance published by AIHC on June 6, 2023.

FDA 45

FDA HIPAA Compliance Regulatory Compliance 45

MedTrainer

JULY 12, 2023

Regulatory Compliance. Organizations like The Joint Commission (TJC), Centers for Medicare and Medicaid Services (CMS), Food and Drug Administration (FDA), and Occupational Safety and Health Administration (OSHA) require incident reporting and response documentation as part of regulatory compliance.

Compliance 52

Compliance Regulatory Compliance FDA Medicaid 52

MedTrainer

JULY 12, 2023

Regulatory Compliance. Organizations like The Joint Commission (TJC), Centers for Medicare and Medicaid Services (CMS), Food and Drug Administration (FDA), and Occupational Safety and Health Administration (OSHA) require incident reporting and response documentation as part of regulatory compliance.

Compliance 52

Compliance Regulatory Compliance FDA Medicaid 52

Exeed Regulatory Compliance

JULY 31, 2020

In a major crisis like this, it is good to know that the FDA has a special authority to quickly allow marketing of medical products that can help diagnose, mitigate or treat this highly infectious disease. If the answer is yes, then FDA may not issue an EUA.

FDA 52

FDA COVID-19 US Department of Health and Human Services Public Health 52

Healthcare IT Today

AUGUST 21, 2023

FDA’s Drug Supply Chain Security Act (DSCSA). RFID’s Potential: Improved Efficiency, Safety, and Regulatory Compliance RFID technology offers significant potential for improving efficiency and patient safety in healthcare applications.

HIPAA 86

HIPAA Regulatory Compliance Hospitals FDA 86

Healthcare IT Today

JUNE 7, 2023

DSI and Predictive Models ONC is clearly attempting to leverage its certification program to help the Food and Drug Administration (FDA) increase transparency related to decision alerts, but this seems to be an inefficient and burdensome application of the certification lever.

FDA 75

FDA Compliance Regulatory Compliance Medicaid 75

Dot Compliance

MARCH 17, 2022

Dot Compliance’s out of the box, holistic, cloud-based QMS solutions are configured with best practices that meet FDA, ISO, and GxP regulations. Medical Device : Medical device manufacturers rely on our QMS solutions for all core quality assurance processes, training, regulatory compliance, and document control.

Compliance 52

Compliance Regulatory Compliance Records Management FDA 52

Exeed Regulatory Compliance

OCTOBER 26, 2020

A double-blinded, placebo-controlled, randomized clinical trial provides support for FDA approval of Remdesivir for treating COVID-19. The FDA has just approved a new antiviral drug, Remdesivir from Gilead Sciences , for treating COVID-19 patients needing acute care in a hospital. FDA is requiring additional post-market studies.

COVID-19 52

COVID-19 FDA Hospitals Public Health 52

Exeed Regulatory Compliance

MARCH 21, 2020

Industry is rapidly developing novel coronavirus diagnostic tests for emergency use authorization by the FDA. There is one piece of good news that the FDA has very rapidly approved several tests in the last 2 weeks under the Emergency Use Authorization and more are expected to follow. What’s the secret to its success?

FDA 52

FDA Governance 52

HIT Consultant

JULY 12, 2023

PV signal teams must balance growing workloads with maintaining regulatory compliance. Take the Sentinel Initiative — a national electric system created by the FDA designed to answer questions about approved medical products like vaccines, drugs, and medical devices.

Regulatory Compliance 52

Regulatory Compliance Compliance Medical Billing FDA 52

Dot Compliance

APRIL 12, 2022

Then we will provide general guidelines for producing labels that will benefit your customers and meet regulatory obligations. The FDA definition of a medical device is something that diagnoses, cures, treats, or prevents a disease or health condition, or otherwise alters the structure or function of the body. US FDA Requirements.

FDA 52

FDA Compliance Regulatory Compliance 52

Exeed Regulatory Compliance

MARCH 5, 2020

FDA Guidance on EUA, Jan 2017 *Notes: Section 564 as in the Food, Drug and Cosmetic (FD&C Act); PAHPRA refers to the Pandemic and All-Hazards Preparedness Reauthorization Act of 2015 One area of current concern is the lack of diagnostic testing capability in the US to rapidly detect and confirm new cases.

US Department of Health and Human Services 52

US Department of Health and Human Services FDA Public Health COVID-19 52

Exeed Regulatory Compliance

JULY 20, 2020

The Accuracy of Covid-19 Antibody Tests As we write this blog, the FDA has authorized 30 different antibody tests for Emergency Use. The second risk is related to the FDA Emergency Use Authorization process itself. Under normal circumstances, FDA would require a lot more data on clinical validation before approving these tests.

COVID-19 52

COVID-19 FDA Public Health 52

Dot Compliance

SEPTEMBER 11, 2022

FDA 21 CFR Part 11 is a rule that specifies how businesses that are subject to FDA regulation, such as those in the medical device, pharmaceutical, and other industries, should manage their electronic records and electronic signatures. Additionally, any system utilized to provide data to the FDA must comply with Part 11.

Compliance 52

Compliance FDA Regulatory Compliance 52

MedTrainer

JUNE 5, 2023

After years in limbo, USP <800> compliance will be required, effective November 1, 2023. It’s the first USP standard that’s enforceable by State Boards of Pharmacy, OSHA, and the FDA. It’s vital for organizations to have demonstrable evidence of compliance and documentation to prove alignment with all required standards.

Compliance 52

Compliance FDA Regulatory Compliance Hospitals 52

Healthcare IT Today

JANUARY 8, 2024

While each company successfully gained FDA approvals, the current market acceptance for prescription digital therapeutics is low and improvements will take years. They will continue to run clinical trials to confirm their claims and value proposition but will not seek FDA approvals.

Pharmaceutical Industry 82

Pharmaceutical Industry Due Diligence Compliance Regulatory Compliance 82

Bill of Health

APRIL 4, 2024

Although the cross-sectoral AI legislation that is now introduced by the European Commission’s Digital Strategy aims to be integrated with existing sectoral legislation such as the MDR, the IVDR and the Machinery Directive, it is uncertain how overlapping regulatory compliance requirements for AI-driven medical devices will be managed in practice.

FDA 282

FDA Regulatory Compliance Malpractice Health Insurance 282

Dot Compliance

JANUARY 14, 2022

FDA’s Safer Technologies Program (SteP) for Medical Devices. The Safer Technologies Program (SteP) is a new, voluntary FDA program for medical devices and device-led combination products that enhance the safety of treatments for non-threatening conditions. Source: [link].

Compliance 52

Compliance FDA Regulatory Compliance Governance 52

Exeed Regulatory Compliance

OCTOBER 19, 2020

The FDA is now reviewing an Emergency Use Authorization of this treatment, which will make it available for broader use. In the first video of our series, we are discussing the antibody “cocktail” from Regeneron that shows potential for an early intervention with symptomatic COVID-19 patients.

COVID-19 52

COVID-19 Hospitals FDA 52

Dot Compliance

SEPTEMBER 11, 2022

There is undoubtedly no shortage of rules that directly affect the pharmaceutical sector in today’s regulatory environment, particularly given that pharmaceutical goods are supplied abroad. Considering ISO 9001:2015 certifications makes sense for pharmaceutical managers given the requirement for compliance, quality, and safety.

Pharmaceutical Industry 52

Pharmaceutical Industry Compliance FDA Regulatory Compliance 52

Healthcare IT Today

DECEMBER 28, 2023

As a result, companies are grappling with how to maintain quality assurance and regulatory compliance as more frequent software updates are required and software complexity grows. In building out its solutions, Ketryx spent years designing products around FDA regulations and quality standards.

FDA 89

FDA Regulatory Compliance Compliance 89

Health Care Law Brief

OCTOBER 27, 2021

This means that although ketamine is approved by the FDA for some medical uses, it is not specifically approved to treat depression. Ketamine is a Schedule III controlled substance. [4] 4] Currently, with certain exceptions, the use of ketamine for depression and related behavioral health matters is “off label.”

Licensing 40

Licensing Telemedicine COVID-19 FDA 40

Health Care Law Brief

JUNE 2, 2022

How will the marketing comply with the FDA rules regarding the marketing of prescription drugs and/or professional practice rules applicable to licensees? Does the state impose any other requirements or restrictions upon the prescribing of controlled substances, beyond the requirements imposed by the Federal Controlled Substances Act?

Public Health 52

Public Health Compliance COVID-19 Licensing 52